Search results for the GEO ID: GSE9827
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM247172
GPL96
CD34+ CTR 1 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of healthy control Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247191
GPL96
CD34+ CTR 2 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of healthy control Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247944
GPL96
CD34+ CTR 3 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of healthy control Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247958
GPL96
CD34+ CTR 4 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of healthy control Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247959
GPL96
CD34+ ET 1 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247960
GPL96
CD34+ ET 2 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247961
GPL96
CD34+ ET 3 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247962
GPL96
CD34+ ET 4 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM247963
GPL96
CD34+ ET 5 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248011
GPL96
CD34+ ET 6 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248113
GPL96
CD34+ ET 7 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248157
GPL96
CD34+ ET 8 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248158
GPL96
CD34+ ET 9 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248159
GPL96
CD34+ ET 10 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248161
GPL96
CD34+ ET 12 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248162
GPL96
CD34+ ET 13 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248163
GPL96
CD34+ ET 14 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248164
GPL96
CD34+ ET 15 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient with the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
GSM248167
GPL96
CD34+ ET 16 Bone Marrow CD34+ progenitor cells CD34+ hematopoietic progenitors purified from bone marrow of Essential Thrombocythemia (ET) patient without the JAK2V617F mutation Two-cycle target labeling assays, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed, using Affymetrix standard protocols (Affymetrix, Santa Clara, CA).
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes